CS Paper Radar

Admissible Diffusion for Multimodal Interventional Trajectories

Xing Han, Shravan Chaudhari, Jiarui Shao, Paul Pu Liang, Suchi Saria

cs.LG ·submitted 2026-09-28 06:52 UTC · v1

Abstract

Generating a plausible clinical trajectory does not establish what would happen under a different treatment. We present ADMIT, a framework combining irregular multimodal representations, treatment-conditioned latent diffusion and explicit constraints on generated states or actions. We formulate its interventional target through sequential g-computation and distinguish causal assumptions from constraint satisfaction. Its admissibility mechanism translates physiological prior knowledge into explicit constraints on generated states and proposed actions. Treatment-exposure dynamics condition latent transitions, while state projection or action gating applies the constraints during rollout so that they influence subsequent trajectory generation. In our preliminary experiments, multimodal inputs improved supervised hidden-state recovery and reduced treatment-contrast error. In a simulated dosing-schedule experiment with leak-free history encoding, ADMIT predicted most of the tumor-volume change caused by redistributing a fixed total dose. An exposure input improved these predictions around a temporary dose reduction whether or not the assumed clearance rate was correct, but reduced the predicted size of a dose effect, and a deterministic recurrent baseline matched ADMIT's average predictions. Exposure projection reduced constraint violations, although enforcement remained incomplete. Semi-synthetic experiments using eICU context illustrated treatment-response generation under fixed and adaptive policies. Observational examples further characterize model treatment sensitivity. ADMIT provides a framework for testing whether complementary observations and physiological restrictions improve intervention trajectories, with representation recovery, effect accuracy and rule enforcement assessed separately.

Comment
15 pages, 3 figures, 7 tables

Closest papers

Nearest neighbours by meaning across the whole index.

Learning the Dose Manifold: A Latent Diffusion Framework for Volumetric Dose Prediction in Automated Radiotherapy Treatment Planning

cs.CV ·2026-10-19 ·J. Boyer-Chammard, R. Vauclin, M. C. Biston, P. Maury, M. Gau +5 more
similarity 0.65
Abstract · 27 pages, 7 figures plus graphical abstract

Automated treatment planning (ATP) aims to reduce the unwarranted inter-planner variability of manual planning, while improving treatment quality and efficiency. Most ATP pipelines rely on the prediction of the achievable three-dimensional dose distribution for a given anatomy and the subsequent optimization of machine parameters to reproduce it. Diffusion-based methods are largely slice-wise due to the high dimensionality of radiotherapy data, and assume a one-to-one mapping between anatomy and optimal dose despite the multi-objective nature of treatment planning. They are evaluated on their ability to match reference doses and rarely on their integration in ATP frameworks. We present LaDose, a latent diffusion framework for fully volumetric dose prediction. An autoencoder learned on dose distributions, trained so that perturbed latents decode to plausible doses, compresses dose maps 128-fold and enables 3D diffusion on a single GPU. Prescription values are represented as exact scalar vectors that bypass the image encoder, avoiding resampling and latent compression. Multiscale classifier-free guidance allows for the modulation of clinical trade-offs at inference, without retraining or additional labeled data. On 900 clinically delivered head-and-neck volumetric modulated arc therapy plans from five centers, LaDose reached a median absolute error of 1.18 Gy (1.4--1.8\% of the prescription) and was the only one of six frameworks free of systematic bias with respect to the reference distribution. Guidance scales acted predictably on target coverage and organ-at-risk sparing. Integrated with direct aperture optimization, the pipeline generated plans in 15.2 minutes; in a blinded review, senior clinicians rated 14 of 15 plans acceptable without editing.

0.12

CaMeWM: A Causal Medical World Model for Generative Tumor Evolution and Treatment Planning

cs.CV cs.LG ·2026-10-17 ·Huanlong Gao, Xuelei He, Fengjun Zhao, Xiaowei He
similarity 0.65
Abstract · 30 pages,8 figures,12 tables,including supplementary material

Treatment planning is intrinsically counterfactual: clinicians must compare how a patient's tumor and survival would evolve under competing regimens, whereas a retrospective cohort records only the regimen received and one follow-up scan. A treatment-conditioned generator trained on such data can therefore reproduce historical treatment allocation rather than simulate the interventional disease dynamics needed to rank regimens. We introduce \textbf{CaMeWM}, a causal medical world model for supported post-TACE tumor evolution and treatment planning. CaMeWM implements one intervention-to-decision loop rather than three independent prediction tasks: it first admits a queried regimen only for clinically comparable histories with empirical treatment support; it then generates a distribution of lesion-local follow-up worlds through an action-conditioned response descriptor, deterministic anchor, and residual 3D diffusion transition; and it finally maps sampled worlds to restricted mean survival time (RMST) with a response-Cox utility model. Under pre-treatment adjustment and positivity, this loop estimates a prespecified, support-restricted g-formula target; all selection and nuisance estimation are fold-local, and the induced policy is evaluated by cross-fitted, censoring-adjusted doubly robust estimation. Across 79 paired out-of-fold episodes, CaMeWM achieves 0.618 SSIM and 0.528 change-map SSIM for follow-up CT transition, while its generated-world survival pathway attains a 0.615 C-index; factual-only AIPW estimates a 9.60-week RMST gain (95\% CI 0.61--18.13) for the frozen policy. CaMeWM provides an inspectable basis for retrospective, support-restricted treatment planning.

0.33

Transformer-Based Reinforcement Learning for Phase I Dose Allocation

cs.LG stat.MLstat.AP ·2026-10-30 ·Shijie Yuan
similarity 0.65
Abstract

Phase I dose-finding trials must learn from sparse toxicity observations while limiting exposure to overly toxic doses. We develop a single reinforcement-learning policy for trials with different numbers of ordered dose levels. Each dose is represented as a token containing its normalized position, accumulated patient count, observed dose-limiting toxicities (DLTs), and current-dose indicator. A Transformer encoder summarizes the dose tokens, trial-conditioned cross-attention produces a fixed-dimensional trial representation, and a three-action policy chooses de-escalation, staying, or escalation. The final maximum tolerated dose (MTD) decision is deliberately kept outside the learned policy: after the planned sample size, weighted isotonic regression and a prespecified safety cap select the dose closest to the target toxicity probability. In the simulations, toxicity-penalized policies reduce DLT burden while unpenalized policies improve selection accuracy at the cost of greater toxicity. These results demonstrate a controllable safety--accuracy trade-off but do not establish superiority over conventional dose-finding designs.

0.16

Adaptive Chemotherapy Control under Tumor Heterogeneity via Reinforcement Learning

cs.LG eess.SY ·2026-09-10 ·Bereket Sitotaw Kidane, Md Samiul Haque Motayed, Shuo Wang
publishedbenchmark similarity 0.63
Abstract · 6 pages. Published in the 2026 American Control Conference (ACC)

Designing effective chemotherapy regimens is hindered by tumor heterogeneity and drug resistance, which complicate the deployment of patient-specific model-based optimal control across diverse populations. We develop and compare closed-loop deep reinforcement learning (DRL) dosing policies with continuous (TD3) and discrete (DQN) action spaces trained on a high-dimensional heterogeneous tumor model. The DRL policies are benchmarked against a Pontryagin's Maximum Principle (PMP)-derived open-loop benchmark. We assess generalization under parametric heterogeneity using a 100-patient virtual cohort with plus or minus 10 percent uniform perturbations in growth and drug-sensitivity parameters. Across this cohort, TD3 achieves higher average tumor reduction, while DQN yields tighter inter-patient dosing consistency, revealing a clear efficacy-consistency trade-off in this study. Our simulations assume full observation of all tumor subpopulations; translation to sparse and noisy clinical measurements will require partial-observability formulations and/or state estimation. Overall, the results show that simulation-trained DRL can learn state-dependent feedback dosing policies that complement open-loop optimal control benchmarks.

0.33

Sign-Constrained Intervention Effects for Domain-Generalizable ICU World Models

cs.CE ·2026-10-08 ·Zhen Xu, Nicholas Konz, Zhen Tan, Zachary Plotkin, Tianlong Chen
similarity 0.61
Abstract · 24 pages, 6 figures, 15 tables

Predicting how a patient's vital signs respond to an intervention is a central question in intensive care. World models can do so by learning dynamics as a function of prior actions. However, such models tend to be brittle outside of training data. Clinicians choose drug dosages based on the patient's state, so the association a model learns between dose and outcome runs opposite to the drug's effect, generalizing poorly to out-of-distribution (OOD) dosing practices. Yet, pharmacological information provides the directional effects of different drugs, which are invariant to OOD shifts. To resolve the OOD sensitivity of current ICU world models, we introduce PHYSIO WORLD, which isolates an intervention's effect by evaluating a forward pass twice: once under recorded doses, and once with those doses set to zero. The difference is projected onto pharmacologically admissible effect directions stated by 70 rules over 28 drugs, leaving the magnitude to be learned from data. Across five distribution-shift parameters over cohorts from three intensive-care databases, and against forecasters, counterfactual models, and invariance objectives, PHYSIO WORLD attains the lowest OOD RMSE in every setting, improving on the strongest external baseline by 8-12%, while matching the in-distribution error of its backbone. Reversing the pharmacological directions degrades accuracy below the backbone, and data-mined directions recover almost no gain, indicating the improvement derives from the content of the pharmacological knowledge. The construction may extend to other settings where the sign of an effect is known in advance and its magnitude is confounded by treatment assignment.

0.17

PerturbRx: Learning Treatment-Conditioned Latent Transitions for Patient Drug Response Prediction

cs.LG q-bio.QM ·2026-08-21 ·Yoshitaka Inoue, Minoh Jeong, Alfred Hero, Rui Kuang, Augustin Luna
similarity 0.60
Abstract

Scarce data and tumor heterogeneity limit patient-level cancer treatment-response prediction. Existing approaches predict response from pretreatment molecular profiles and drug representations, without explicitly modeling the molecular changes expected under treatment. We propose PerturbRx, a treatment-conditioned representation learning framework that learns intervention-induced latent transitions and uses them as patient-drug response features. PerturbRx trains a drug- and dose-conditioned transition predictor from context-matched but cell-unpaired control and treated single-cell populations, then freezes and transfers the predictor to pretreatment patient profiles without requiring post-treatment measurements. The transition is combined with patient and drug representations to predict response. Across TCGA and patient-derived xenograft benchmarks, PerturbRx achieves the strongest aggregate predictive performance among the evaluated methods. These results support perturbation-pretrained latent transitions as useful representations for patient-level drug-response prediction.

0.25

Behavioral Cloning Outperforms Entropy-Regularized RL: Critic-Driven Failure of Actor-Critic Methods on Adaptive Tumor Treatment

cs.LG ·2026-09-06 ·Aleksandar Dimitrov, Giacomo Spigler
similarity 0.59
Abstract · 9 pages, 3 figures

Adaptive dosing requires policies that reduce tumor burden without excessive toxicity. Learned dosing policies are typically judged against historical or heuristic comparators, which cannot show whether a policy has found the best behavior available. We instead study a three-population tumor-control ODE in which optimal-control analysis fixes the form of a good schedule -- bang-bang dosing punctuated by a singular arc -- and construct a numerical controller of that form as a proxy for near-optimal behavior. Judged against this reference under a sustained-cure criterion -- 200 consecutive days below 5% carrying capacity -- Soft Actor-Critic (SAC) trained from scratch never reaches cure. Behavioral cloning (BC) of the reference reproduces it (100% sustained cure, 30/30 seeds), but SAC fine-tuning of the cloned policy destroys it across five entropy coefficients, and TD3 and BC-regularized SAC fail identically; the pattern persists under multiplicative pharmacokinetic action noise. Along curative trajectories the post-collapse critic ranks the collapsed-policy action above the reference action in 96% of states, concentrated in the maintenance phase, and the policy settles into a non-curative adaptive-therapy equilibrium. The reference is what makes this legible: against a heuristic comparator the fine-tuned policy would read as a competent controller rather than a failure.

0.29

DISCERN: Identifiable Disease Evidence for Generalizable Medical Multimodal Learning

cs.LG cs.CVq-bio.QM ·2026-10-09 ·Xiaoguang Zhu, Pengyi Jiang, Juncen Guo, Jingyi Wu, Lianlong Sun +1 more
similarity 0.58
Abstract

Clinical multimodal models can learn enrollment shortcuts shared across modalities and fail on new cohorts. We model these data through a latent structural causal model: disease state and background factors generate physiology through shared mechanisms, while cohorts differ in selection and measurement. Holding acquisition fixed, we identify conditional disease evidence without observing disease-state labels or recovering the full causal model. In common Gaussian coordinates, cross-cohort state alignment and natural-parameter changes identify a minimal selection statistic; conditioning on it removes enrollment-dependent evidence and yields an identifiable reference posterior within the specified shift family. State-dependent interactions can carry evidence invisible to individual-modality posteriors, motivating joint, information-preserving representations. DISCERN combines an information-lattice encoder, a latent-state model, and an outcome head through joint training. Under reversed synthetic enrollment on known latent coordinates, conditioning raises state AUROC from 0.043 to 0.883 and from 0.265 to 0.825, while random conditioning does not. Exploratory cross-database mortality experiments between eICU and MIMIC-IV improve AUROC over matched empirical risk minimization by 0.036 and 0.035. Learned-coordinate diagnostics distinguish preservation of state information from identification of the coordinates required by the estimator.

0.27